M
Maria de la Fuente
Researcher at Group Health Research Institute
Publications - 91
Citations - 3866
Maria de la Fuente is an academic researcher from Group Health Research Institute. The author has contributed to research in topics: Thrombin & Cancer. The author has an hindex of 30, co-authored 91 publications receiving 3211 citations. Previous affiliations of Maria de la Fuente include Case Western Reserve University & University of London.
Papers
More filters
Journal ArticleDOI
Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture.
Eduardo Anitua,Isabel Andia,Mikel Sánchez,Juan Azofra,M del Mar Zalduendo,Maria de la Fuente,Paquita Nurden,Alan T. Nurden +7 more
TL;DR: It is suggested that administering autologous platelet‐rich clots may be beneficial to the treatment of tendon injuries by inducing cell proliferation and promoting the synthesis of angiogenic factors during the healing process.
Journal ArticleDOI
Chitosan-based nanostructures: a delivery platform for ocular therapeutics.
Maria de la Fuente,Manuela Raviña,Patrizia Paolicelli,Alejandro Sánchez,Begoña Seijo,María J. Alonso +5 more
TL;DR: The results collected up until now suggest the potential of the delivery platform based on the polysaccharide chitosan and the subsequent need of a full preclinical evaluation in order to satisfy the specific regulatory demands of this mode of administration.
Journal ArticleDOI
Novel Hyaluronic Acid-Chitosan Nanoparticles for Ocular Gene Therapy
TL;DR: Evidence is given of the potential of HA-CS nanoparticles for the targeting and further transfer of genes to the ocular surface.
Journal ArticleDOI
Autologous fibrin matrices: a potential source of biological mediators that modulate tendon cell activities.
Eduardo Anitua,Mikel Sánchez,Alan T. Nurden,Mar Zalduendo,Maria de la Fuente,Gorka Orive,Juan Azofra,Isabel Andia +7 more
TL;DR: Results indicate that administration of fibrin matrices is a safe and easy strategy that may open new avenues for enhancing tissue healing and remodelling and influences the process of regeneration in clinical situations characterised by a poor healing outcome.
Journal ArticleDOI
Reciprocal actions of platelet-secreted TGF-beta1 on the production of VEGF and HGF by human tendon cells.
Eduardo Anitua,Mikel Sánchez,Alan T. Nurden,Mar Zalduendo,Maria de la Fuente,Juan Azofra,Isabel Andia +6 more
TL;DR: The balance between TGF-&bgr;1 and the pools of platelet-secreted molecules may have important therapeutic implications in the control of angiogenesis and fibrosis.